CEO and Co-Founder, 23andMe
Anne co-founded 23andMe in 2006 after a decade spent in healthcare investing, focused primarily on biotechnology companies. Her hope was to empower consumers with access to their own genetic information and to create a way to generate more personalized information so that researchers could better understand and develop new drugs and diagnostics. 23andMe has built one of the world’s largest databases of individual genetic information and under Anne’s leadership 23andMe has made significant advances in bringing personalized medicine directly to the public. Anne graduated from Yale University with a BS in Biology.